NOxin

NOxin is a brand of nicotine replacement therapy products, including nicotine gum, lozenges, inhalers, patches, and nasal sprays. It was originally developed by the Swedish pharmaceutical company Pharmacia & Upjohn, which later became Pfizer. NOxin products are designed to help individuals quit smoking by providing a controlled dose of nicotine without the harmful effects of tobacco smoke.

The brand offers a range of products to cater to different preferences and needs. NOxin gum is available in various strengths, including 2mg, 4mg, and 8mg per piece. NOxin lozenges come in 2mg and 4mg strengths, and are designed to be placed under the tongue for a quick nicotine delivery. NOxin inhalers provide a fast-acting nicotine solution, with strengths ranging from 0.2mg to 2mg per inhalation. NOxin patches are available in 14mg, 21mg, and 28mg strengths, and are designed to be worn on the skin for a continuous nicotine delivery. NOxin nasal spray is available in 2mg and 4mg strengths, and is designed to be sprayed into the nostrils for a quick nicotine delivery.

NOxin products are available in various countries around the world, and are regulated by local health authorities. The brand is known for its commitment to providing effective and safe nicotine replacement therapy products to help individuals quit smoking. NOxin products are not intended for use by individuals under the age of 18, and should be used in accordance with the product instructions and warnings.